Sarepta Therapeutics Inc (NAS:SRPT)
$ 114.37 0.05 (0.04%) Market Cap: 10.92 Bil Enterprise Value: 11.12 Bil PE Ratio: 74.27 PB Ratio: 8.94 GF Score: 85/100

Sarepta Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 11, 2021 / 06:00PM GMT
Release Date Price: $71.02 (+1.41%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Hello, everybody, good afternoon. Welcome back to the Bank of America Health Care Conference. It's my pleasure to have our next presenting company with us for the next 30 minutes. We have a couple of members from the Sarepta management team with us; CEO, Doug Ingram; as well as CFO, Ian Estepan. Gentlemen, good afternoon. It's always a pleasure to host you guys, and thanks for doing us the favor of participating in our conference this year.

Douglas S. Ingram
Sarepta Therapeutics, Inc. - President, CEO & Director

Tazeen, thank you very much. We're honored to be here.

Questions & Answers

Tazeen Ahmad
BofA Securities, Research Division - VP

I don't think we need to waste time asking you to describe to everyone what Sarepta does. I think that is I think everyone is quite familiar, so maybe we can go into details if that's okay, though. Maybe talk about what you think the most important catalysts that are upcoming are for the rest of the year for the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot